<div>Investigators from Saint Louis University discuss their recent study comparing GLP-1 receptor agonists with SGLT2 inhibitors.</div>

Investigators from Saint Louis University discuss their recent study comparing GLP-1 receptor agonists with SGLT2 inhibitors.

Comparing GLP-1 Receptor Agonists with SGLT2 Inhibitors for Type 2 Diabetes Patients

<div>Your destination feed for medical, health care and clinical science podcasts courtesy of HCPLive—featuring our shows Medical Ethics Unpacked, New Insight, and 5 Stories in Under 5.<br>
<br>
<br>
<br>

</div>

News

Science

Medicine

Health & Fitness

Business News

Life Sciences

Your destination feed for medical, health care and clinical science podcasts courtesy of HCPLive—featuring our shows Medical Ethics Unpacked, New Insight, and 5 Stories in Under 5.

Your destination feed for medical, health care and clinical science podcasts courtesy of HCPLive—featuring our shows Medical Ethics Unpacked, New Insight, and 5 Stories in Under 5.<br>
<br>
<br>
<br>



Share Comparing GLP-1 Receptor Agonists with SGLT2 Inhibitors for Type 2 Diabetes Patients

Sign up to save your podcasts

Comparing GLP-1 Receptor Agonists with SGLT2 Inhibitors for Type 2 Diabetes Patients

Comparing GLP-1 Receptor Agonists with SGLT2 Inhibitors for Type 2 Diabetes Patients

More shows like HCPLive Podcasts

Evidence-Based GI: An ACG Publication and Podcast